Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extracts.

Guasch L, Sala E, Ojeda MJ, Valls C, Bladé C, Mulero M, Blay M, Ardévol A, Garcia-Vallvé S, Pujadas G.

PLoS One. 2012;7(9):e44972. doi: 10.1371/journal.pone.0044972. Epub 2012 Sep 21.

2.

Identification of PPARgamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity.

Guasch L, Sala E, Mulero M, Valls C, Salvadó MJ, Pujadas G, Garcia-Vallvé S.

PLoS One. 2013;8(2):e55889. doi: 10.1371/journal.pone.0055889. Epub 2013 Feb 6.

3.

Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays.

Guasch L, Ojeda MJ, González-Abuín N, Sala E, Cereto-Massagué A, Mulero M, Valls C, Pinent M, Ardévol A, Garcia-Vallvé S, Pujadas G.

PLoS One. 2012;7(9):e44971. doi: 10.1371/journal.pone.0044971. Epub 2012 Sep 12.

4.

Recent progress in natural products as DPP-4 inhibitors.

Gao Y, Zhang Y, Zhu J, Li B, Li Z, Zhu W, Shi J, Jia Q, Li Y.

Future Med Chem. 2015;7(8):1079-89. doi: 10.4155/fmc.15.49. Review.

PMID:
26062402
5.

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

Ojeda-Montes MJ, Ardid-Ruiz A, Tomás-Hernández S, Gimeno A, Cereto-Massagué A, Beltrán-Debón R, Mulero M, Garcia-Vallvé S, Pujadas G, Valls C.

Future Med Chem. 2017 Dec;9(18):2129-2146. doi: 10.4155/fmc-2017-0080. Epub 2017 Nov 27.

PMID:
29172693
6.

Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham.

Gallego M, Aristoy MC, Toldrá F.

Meat Sci. 2014 Feb;96(2 Pt A):757-61. doi: 10.1016/j.meatsci.2013.09.014. Epub 2013 Sep 25.

PMID:
24200567
7.

Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.

Duffy NA, Green BD, Irwin N, Gault VA, McKillop AM, O'Harte FP, Flatt PR.

Eur J Pharmacol. 2007 Jul 30;568(1-3):278-86. Epub 2007 May 13.

PMID:
17573070
8.

Plants Fagonia cretica L. and Hedera nepalensis K. Koch contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity.

Saleem S, Jafri L, ul Haq I, Chang LC, Calderwood D, Green BD, Mirza B.

J Ethnopharmacol. 2014 Oct 28;156:26-32. doi: 10.1016/j.jep.2014.08.017. Epub 2014 Aug 26.

PMID:
25169215
9.

Recent patents of dipeptidyl peptidase IV inhibitors.

Mendieta L, Tarrago T, Giralt E.

Expert Opin Ther Pat. 2011 Nov;21(11):1693-741. doi: 10.1517/13543776.2011.627325. Review.

PMID:
22017411
10.

Study on gluco-regulatory potential of glimepiride sulfonamide using in silico, in vitro and in vivo approaches.

Parmar HS, Bhinchar MK, Bhatia M, Chordia N, Raval I, Chauhan DS, Manivannan E, Jatwa R, Kumar A.

Curr Pharm Des. 2014;20(32):5212-7.

PMID:
24641189
11.

Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.

Tanwar O, Tanwar L, Shaquiquzzaman M, Alam MM, Akhter M.

Bioorg Med Chem Lett. 2014 Aug 1;24(15):3447-51. doi: 10.1016/j.bmcl.2014.05.076. Epub 2014 Jun 2.

PMID:
24948564
12.

Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.

Li S, Xu H, Cui S, Wu F, Zhang Y, Su M, Gong Y, Qiu S, Jiao Q, Qin C, Shan J, Zhang M, Wang J, Yin Q, Xu M, Liu X, Wang R, Zhu L, Li J, Xu Y, Jiang H, Zhao Z, Li J, Li H.

J Med Chem. 2016 Jul 28;59(14):6772-90. doi: 10.1021/acs.jmedchem.6b00505. Epub 2016 Jul 19.

PMID:
27396490
13.
14.

DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.

Bae EJ.

Arch Pharm Res. 2016 Aug;39(8):1114-28. doi: 10.1007/s12272-016-0813-x. Epub 2016 Aug 9. Review. Erratum in: Arch Pharm Res. 2016 Sep;39(9):1335.

PMID:
27502601
15.

Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking.

Bharti SK, Krishnan S, Kumar A, Rajak KK, Murari K, Bharti BK, Gupta AK.

Phytomedicine. 2012 Dec 15;20(1):24-31. doi: 10.1016/j.phymed.2012.09.009. Epub 2012 Oct 10.

PMID:
23063145
16.

Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties.

Nongonierma AB, Maux SL, Esteveny C, FitzGerald RJ.

J Sci Food Agric. 2017 Mar;97(4):1093-1101. doi: 10.1002/jsfa.7834. Epub 2016 Jul 5.

PMID:
27271791
17.

Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.

Maezaki H, Banno Y, Miyamoto Y, Moritoh Y, Asakawa T, Kataoka O, Takeuchi K, Suzuki N, Ikedo K, Kosaka T, Sasaki M, Tsubotani S, Tani A, Funami M, Yamamoto Y, Tawada M, Aertgeerts K, Yano J, Oi S.

Bioorg Med Chem. 2011 Aug 1;19(15):4482-98. doi: 10.1016/j.bmc.2011.06.032. Epub 2011 Jul 7. Erratum in: Bioorg Med Chem. 2011 Sep 15;19(18):5742. Moritou, Yuusuke [corrected to Moritoh, Yusuke].

PMID:
21741847
18.

In silico, in vitro and in vivo analyses of dipeptidyl peptidase IV inhibitory activity and the antidiabetic effect of sodium caseinate hydrolysate.

Hsieh CH, Wang TY, Hung CC, Jao CL, Hsieh YL, Wu SX, Hsu KC.

Food Funct. 2016 Feb;7(2):1122-8. doi: 10.1039/c5fo01324k.

PMID:
26796955
19.

Inhibition of dipeptidyl peptidase activity by flavonol glycosides of guava (Psidium guajava L.): a key to the beneficial effects of guava in type II diabetes mellitus.

Eidenberger T, Selg M, Krennhuber K.

Fitoterapia. 2013 Sep;89:74-9. doi: 10.1016/j.fitote.2013.05.015. Epub 2013 May 23.

PMID:
23707747
20.

Identification and characterization of a dipeptidyl peptidase IV inhibitor from aronia juice.

Kozuka M, Yamane T, Nakano Y, Nakagaki T, Ohkubo I, Ariga H.

Biochem Biophys Res Commun. 2015 Sep 25;465(3):433-6. doi: 10.1016/j.bbrc.2015.08.031. Epub 2015 Aug 18.

PMID:
26296465

Supplemental Content

Support Center